Rubicon Research Share Price
NSE: RUBICON | Miscellaneous | Small Cap
Rubicon Research Share Price Today
Rubicon Research Share Price Today
As of 13 Oct 2026, Rubicon Research share price is ₹1540.2. The stock opened at ₹1557.6 and had closed at ₹1548.5 the previous day. During today’s trading session, Rubicon Research share price moved between ₹1,523.90 and ₹1,569.50, with an average price for the day of ₹1546.70. Over the last 52 weeks, the stock has recorded a low of ₹570.75 and a high of ₹1,899.00. In terms of performance, Rubicon Research share price has increased by 84.2% over the past six months and has declined by 0% over the last year.
Rubicon Research Stock Performance
Rubicon Research Share Price Chart
Rubicon Research Share Price Chart
Rubicon Research Company background
Rubicon Research Limited was incorporated on May 6, 1999, as a Private Company as Rubicon Consultants Private Limited, with the RoC. Subsequently, the Companys name was changed from Rubicon Consultants Private Limited to Rubicon Research Private Limited to which a fresh Certificate of Incorporation was issued by the RoC dated September 2, 2002. The Companys status got converted from a Private Company to a Public Company, the name was changed from Rubicon Research Private Limited to Rubicon Research Limited. A fresh Certificate of Incorporation dated July 23, 2024 was issued by the Central Processing Centre, Manesar, Haryana. Rubicon Research is an integrated pharmaceutical company with business encompassing the entire value chain in the research, development and production of pharmaceutical products. The Company is driven by innovation through focused research and development, with an increasing portfolio of specialty products and drugdevice combination products targeting regulated markets, particularly, the United States. It has obtained its GMP manufacturing facilities at Ambernath and Satara in Maharashtra.The Company commenced manufacturing of certain special drugs in Ambernath Manufacturing Facility in 2011. In 2016, the Company acquired majority stake by ECP III Pte Ltd. Further, it acquired majority stake by General Atlantic Singapore RR Pte. Ltd., from ECP III Pte. Ltd. in 2019. In 2021, the Company acquired the business of Meditab Specialities Limited on slump sale as a going concern. In FY 2024, the Company acquired Validus, a New Jersey headquartered marketer of brand name formulation products in the US. It commenced the manufacturing of nasal products at Ambernath Plant in 2024. The Company has acquired Pithampur Manufacturing Facility from Alkem Laboratories Ltd in 2025. The Company came up with its initial public offering of 28,405,841 equity shares of face value of Re 1 each, by raising funds aggregating to Rs 1378 crores, comprising a fresh issue of 10,313,058 equity shares aggregating to Rs 500 crores and the offer for sale of 18,092,783 equity shares aggregating to Rs 878 crores on October 13, 2025.The Company acquired 85% stake in Arinna Lifesciences Limited at Pithampur in April 2026.
Rubicon Research Financial Highlights
For Q1 FY2026–2027, Rubicon Research's revenue reached ₹540.02 crore and profit touched at ₹84.78 crore. As of 13 October 2026, Rubicon Research’s market capitalization reached at ₹25,495.22 crores. Shareholding as of 13 October 2026 shows promoters holding 59.8%, with FIIs at 7.5%, DIIs at 9.5%, and public at 23.3%.
Rubicon Research Fundamental
Market Cap (in crs)
25,495.22
Face Value
1
Turnover (in lacs)
1,859.02
Key Metrics
Rubicon Research Key Financials
View moreRubicon Research Result Highlights
-
Rubicon Research reported a 15.6% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a - of -.
-
Its expenses for the quarter were up by 14.7% QoQ and - - YoY.
-
The net profit increased 24.4% QoQ and - - YoY.
-
The earnings per share (EPS) of Rubicon Research stood at 3.47 during Q2 FY 2025-26.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Rubicon Research Technical Analysis
Delivery & Volume
Delivery Volume %
Day
40.90%
Week
47.60%
Month
55.50%
Resistance & Support
Rubicon Research Peer comparison
CompareIndex Name | Market Price |
|---|---|
803.35 -11.90 (-1.46%)▼ | |
20,565.00 -325.00 (-1.56%)▼ | |
1,013.90 -7.80 (-0.76%)▼ | |
3,144.10 -16.50 (-0.52%)▼ | |
196.66 -0.22 (-0.11%)▼ | |
1,471.30 -16.60 (-1.12%)▼ |
Rubicon Research Latest News
Rubicon Research Share Price FAQs
Rubicon Research share price is ₹1540.2 in NSE and ₹1539.55 in BSE as on 12/10/2026.
Rubicon Research share price in the past 1-year return was 0. The Rubicon Research share hit a 1-year low of Rs. 570.75 and a 1-year high of Rs. 1899.
The market cap of Rubicon Research is Rs. 25495.22 Cr. as of 12/10/2026.
The PE ratios of Rubicon Research is 108.27 as of 12/10/2026.
The PB ratios of Rubicon Research is 18.83 as of 12/10/2026
The Mutual Fund Shareholding in Rubicon Research was 7.23% at the end of 12/10/2026.
You can easily buy Rubicon Research shares in Kotak Neo by opening a demat account and getting the KYC documents verified online.
The 52-week high and low of Rubicon Research share price is ₹1899 and ₹570.75 as of 12/10/2026.
Please be aware that Rubicon Research stock prices are subject to continuous fluctuations due to various factors.